Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey

[1] Manji H, Carr AS, Brownlee WJ, Lunn MP. Neurology in the time of COVID-19. J Neurol Neurosurg Psychiatry. 2020; 91:568–70. ManjiH CarrAS BrownleeWJ LunnMP Neurology in the time of COVID-19 J Neurol Neurosurg Psychiatry 2020 91 568 70 10.1136/jnnp-2020-32341432312872 Search in Google Scholar

[2] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323:1061–9. WangD HuB HuC ZhuF LiuX ZhangJ Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China JAMA 2020 323 1061 9 10.1001/jama.2020.1585704288132031570 Search in Google Scholar

[3] Liu Y, Xia P, Cao W, Liu Z, Ma J, Zheng K, et al. Divergence between serum creatine and cystatin C in estimating glomerular filtration rate of critically ill COVID-19 patients. Ren Fail. 2021; 43:1104–14. LiuY XiaP CaoW LiuZ MaJ ZhengK Divergence between serum creatine and cystatin C in estimating glomerular filtration rate of critically ill COVID-19 patients Ren Fail 2021 43 1104 14 10.1080/0886022X.2021.1948428827450834238117 Search in Google Scholar

[4] Han H, Xie L, Liu R, Yang J, Liu F, Wu K, Chen L, et al. Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China. J Med Virol. 2020; 92:819–23. HanH XieL LiuR YangJ LiuF WuK ChenL Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China J Med Virol 2020 92 819 23 10.1002/jmv.25809722830532232979 Search in Google Scholar

[5] Han H, Yang L, Liu R, Liu F, Wu K-l, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020; 58:1116–20. HanH YangL LiuR LiuF WuK-l LiJ Prominent changes in blood coagulation of patients with SARS-CoV-2 infection Clin Chem Lab Med 2020 58 1116 20 10.1515/cclm-2020-018832172226 Search in Google Scholar

[6] Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77:683–90. MaoL JinH WangM HuY ChenS HeQ Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China JAMA Neurol 2020 77 683 90 10.1001/jamaneurol.2020.1127714936232275288 Search in Google Scholar

[7] Karadaş Ö, Öztürk B, Sonkaya AR. A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurol Sci. 2020; 41:1991–5. KaradaşÖ ÖztürkB SonkayaAR A prospective clinical study of detailed neurological manifestations in patients with COVID-19 Neurol Sci 2020 41 1991 5 10.1007/s10072-020-04547-7731642832588367 Search in Google Scholar

[8] Espíndola OM, Brandão CO, Gomes YCP, Siqueira M, Soares CN, Lima MASD, et al. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development. Int J Infect Dis. 2021; 102:155–62. EspíndolaOM BrandãoCO GomesYCP SiqueiraM SoaresCN LimaMASD Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development Int J Infect Dis 2021 102 155 62 10.1016/j.ijid.2020.10.044759131933127503 Search in Google Scholar

[9] Li YC, Bai W-Z, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92:552–5. LiYC BaiW-Z HashikawaT The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients J Med Virol 2020 92 552 5 10.1002/jmv.25728722839432104915 Search in Google Scholar

[10] Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020; 142:14–22. WhittakerA AnsonM HarkyA Neurological manifestations of COVID-19: a systematic review and current update Acta Neurol Scand 2020 142 14 22 10.1111/ane.13266727303632412088 Search in Google Scholar

[11] Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020; 11:995–8. BaigAM KhaleeqA AliU SyedaH Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms ACS Chem Neurosci 2020 11 995 8 10.1021/acschemneuro.0c00122709417132167747 Search in Google Scholar

[12] Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, et al. On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol. 2020; 72:1059–63. HendersonLA CannaSW SchulertGS VolpiS LeePY KernanKF On the alert for cytokine storm: immunopathology in COVID-19 Arthritis Rheumatol 2020 72 1059 63 10.1002/art.41285726234732293098 Search in Google Scholar

[13] Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021; 33:155–62. LiuY SawalhaAH LuQ COVID-19 and autoimmune diseases Curr Opin Rheumatol 2021 33 155 62 10.1097/BOR.0000000000000776788058133332890 Search in Google Scholar

[14] Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int. 2020; 40:1539–54. ShahS DandaD KavadichandaC DasS AdarshMB NegiVS Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment Rheumatol Int 2020 40 1539 54 10.1007/s00296-020-04639-9736012532666137 Search in Google Scholar

[15] von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007; 147:573–7. von ElmE AltmanDG EggerM PocockSJ GøtzschePC VandenbrouckeJP STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies Ann Intern Med 2007 147 573 7 10.1097/EDE.0b013e318157765418049194 Search in Google Scholar

[16] Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al.; RECORD Working Committee. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015; 12:e1001885. doi: 10.1371/journal.pmed.1001885 BenchimolEI SmeethL GuttmannA HarronK MoherD PetersenI RECORD Working Committee The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement PLoS Med 2015 12 e1001885 10.1371/journal.pmed.1001885 459521826440803 Open DOISearch in Google Scholar

[17] Bolay H, Gül A, Baykan B. COVID-19 is a real headache! Headache. 2020; 60:1415–21. BolayH GülA BaykanB COVID-19 is a real headache! Headache 2020 60 1415 21 10.1111/head.13856727289532412101 Search in Google Scholar

[18] Yin S, Huang M, Li D, Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis. 2021; 51:1107–10. YinS HuangM LiD TangN Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 J Thromb Thrombolysis 2021 51 1107 10 10.1007/s11239-020-02105-8712412832246317 Search in Google Scholar

[19] Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, et al. SARS-CoV-2 and stroke in a New York Healthcare system. Stroke. 2020; 51:2002–11. YaghiS IshidaK TorresJ Mac GroryB RazE HumbertK SARS-CoV-2 and stroke in a New York Healthcare system Stroke 2020 51 2002 11 10.1161/STROKEAHA.120.030335725876432432996 Search in Google Scholar

[20] Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS, et al. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci. 2020; 417:117085. doi: 10.1016/j.jns.2020.117085 Sharifian-DorcheM HuotP OsherovM WenD SaverianoA GiacominiPS Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic J Neurol Sci 2020 417 117085 10.1016/j.jns.2020.117085 741316232871412 Open DOISearch in Google Scholar

[21] Morelli N, Rota E, Terracciano C, Immovilli P, Spallazzi M, Colombi D, et al. The baffling case of ischemic stroke disappearance from the casualty department in the COVID-19 era. Eur Neurol. 2020; 83:213–5. MorelliN RotaE TerraccianoC ImmovilliP SpallazziM ColombiD The baffling case of ischemic stroke disappearance from the casualty department in the COVID-19 era Eur Neurol 2020 83 213 5 10.1159/000507666 Search in Google Scholar

[22] Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020; 18:1094–9. TangN BaiH ChenX GongJ LiD SunZ Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy J Thromb Haemost 2020 18 1094 9 10.1111/jth.14817 Search in Google Scholar

[23] Lu L, Xiong W, Liu D, Liu J, Yang D, Li N, et al. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: a retrospective multicenter study. Epilepsia. 2020; 61:e49–53. doi: 10.1111/epi.16524 LuL XiongW LiuD LiuJ YangD LiN New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: a retrospective multicenter study Epilepsia 2020 61 e49 53 10.1111/epi.16524 Open DOISearch in Google Scholar

[24] Somani S, Pati S, Gaston T, Chitlangia A, Agnihotri S. De novo status epilepticus in patients with COVID-19. Ann Clin Transl Neurol. 2020; 7:1240–4. SomaniS PatiS GastonT ChitlangiaA AgnihotriS De novo status epilepticus in patients with COVID-19 Ann Clin Transl Neurol 2020 7 1240 4 10.1002/acn3.51071 Search in Google Scholar

[25] Balloy G, Leclair-Visonneau L, Péréon Y, Magot A, Peyre A, Mahé P-J, Derkinderen P. Non-lesional status epilepticus in a patient with coronavirus disease 2019. Clin Neurophysiol. 2020; 131:2059–61. BalloyG Leclair-VisonneauL PéréonY MagotA PeyreA MahéP-J DerkinderenP Non-lesional status epilepticus in a patient with coronavirus disease 2019 Clin Neurophysiol 2020 131 2059 61 10.1016/j.clinph.2020.05.005 Search in Google Scholar

[26] Lyons S, O’Kelly B, Woods S, Rowan C, Brady D, Sheehan G, Smyth S. Seizure with CSF lymphocytosis as a presenting feature of COVID-19 in an otherwise healthy young man. Seizure. 2020; 80:113–4. LyonsS O’KellyB WoodsS RowanC BradyD SheehanG SmythS Seizure with CSF lymphocytosis as a presenting feature of COVID-19 in an otherwise healthy young man Seizure 2020 80 113 4 10.1016/j.seizure.2020.06.010 Search in Google Scholar

[27] Ying W, Qian Y, Kun Z. Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic. Res Social Adm Pharm. 2021; 17:1978–83. YingW QianY KunZ Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic Res Social Adm Pharm 2021 17 1978 83 10.1016/j.sapharm.2020.04.001 Search in Google Scholar

[28] Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020; 19:383–4. ZhaoH ShenD ZhouH LiuJ ChenS Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 2020 19 383 4 10.1016/S1474-4422(20)30109-5 Search in Google Scholar

[29] Matta S, Chopra KK, Arora VK. Morbidity and mortality trends of Covid 19 in top 10 countries. Indian J Tuberc. 2020; 67(4S):S167–72. MattaS ChopraKK AroraVK Morbidity and mortality trends of Covid 19 in top 10 countries Indian J Tuberc 2020 67 4S S167 72 10.1016/j.ijtb.2020.09.031754389633308665 Search in Google Scholar